Syndax Pharmaceuticals Inc share price logo

Syndax Pharmaceuticals Inc

NASDAQ: SNDX

Small Cap

$20.48

-0.17

(-0.82%)

Live

as on

Syndax Pharmaceuticals Inc Stock Performance

as on May 8, 2026 at 1:10 am IST

  • Day's High

    $20.48
    $20.84

    1.76%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $8.58
    $25.59
    downward going graph

    58.11%

    Downside

    24.95%

    Upside

    downward going graph

Syndax Pharmaceuticals Inc share price movements today

Previous Close
$20.65
Open
$20.71
Volume
85.5K
Day's Low - High
$20.48 - $20.84
52 Week Low - High
$8.58 - $25.59

Syndax Pharmaceuticals Inc Historical Returns

1 Month Return
-16.19 %
3 Month Return
-1.71 %
1 Year Return
+ 106.71 %
3 Year Return
+ 2.94 %
5 Year Return
+ 28.74 %

Syndax Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Syndax Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.8B

EPS (TTM)

-1.7695

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-224.2M

Revenue (TTM)

217.2M

Profit Margin

-112.01%

Return On Equity TTM

-189.53%

Syndax Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Syndax Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.8B28.74%NA-112.01%
BUY$40.5B130.77%76.3212.55%
BUY$108.5B98.9%25.3835.51%
NA$32.5BNA70.895.37%
BUY$75.6B45.15%17.629.65%

Stock Returns calculator for Syndax Pharmaceuticals Inc Stock including INR - Dollar returns

The Syndax Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Syndax Pharmaceuticals Inc investment value today

Current value as on today

₹2,28,037

Returns

₹1,28,037

(+128.04%)

Returns from Syndax Pharmaceuticals Inc Stock

₹1,05,005 (+105.01%)

Dollar Impact

₹23,032 (+23.03%)

Analyst Recommendation on Syndax Pharmaceuticals Inc Stock

Based on 19 analysts

BUY

89.47%

Buy

10.53%

Hold

0.00%

Sell

Based on 19 analysts, 89.47% of analysts recommend a 'BUY' rating for Syndax Pharmaceuticals Inc. Average target price of $39.58

Syndax Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Syndax Pharmaceuticals Inc.

What analysts predicted

48.26%UPSIDE

Target Price

$39.58

Current Price

$20.48

Analyzed by

19 Analysts

Target

$39.58

Syndax Pharmaceuticals Inc target price $39.58, a slight upside of 48.26% compared to current price of $20.48. According to 19 analysts rating.

Indian Investors' Interest in Syndax Pharmaceuticals Inc Stock

Search interest for Syndax Pharmaceuticals Inc Stock has decreased by -22% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-22% versus previous 30 day period

Syndax Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
-
3
12
7
20
37
45
68
64
Gross Profit
0
0
3
12
7
19
36
43
70
62
Operating Income
-77
-79
-74
-89
-96
-83
-69
-57
-62
-34
EBITDA
-72
-72
-68
-84
-89
-83
-63
-52
-15
-30
Interest Expense
0
0
0
0
4
8
7
8
52
11
Depreciation
0
0
0
0
-
-
-
0
0
0
Income Before Tax
-72
-72
-68
-84
-94
-84
-71
-60
-68
-42
Income Tax Expense
4
0
-
0
-
-
-
-
-
-
Net Income
-72
-72
-68
-84
-94
-84
-71
-60
-68
-42
Net Profit Margin
-13521.08%
0.00%
-1944.66%
-673.01%
-1226.16%
-423.34%
-189.28%
-132.36%
-99.32%
-65.79%

Syndax Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
2
1
1
1
139
126
-
23
172
Gross Profit
1
2
1
1
1
139
0
0
22
165
Operating Income
-43
-61
-75
-57
-71
26
-151
-229
-339
-273
EBITDA
-43
-61
-75
-57
-71
26
-151
-209
-313
-251
Interest Expense
0
1
1
1
2
1
3
0
4
33
Depreciation
-
0
0
0
0
0
0
0
0
0
Income Before Tax
-44
-60
-73
-56
-73
24
-149
-209
-318
-285
Income Tax Expense
0
0
1
0
0
0
-5
-
-318
-
Net Income
-44
-60
-73
-55
-73
24
-143
-209
-318
-285
Net Profit Margin
-3645.25%
-2884.35%
-4875.48%
-3688.53%
-4816.68%
17.84%
-113.57%
0.00%
-1346.11%
-165.60%

Syndax Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-72
-68
-84
-94
-84
-71
-60
-68
-42
Operating Cash Flow
-83
-71
-62
-57
-95
-87
-70
-69
-50
Investing Cash Flow
-99
61
86
-268
94
41
72
81
38
Financing Cash Flow
2
0
3
347
0
0
6
5
7
Change in Cash
-180
-9
27
21
0
-45
8
18
-4

Syndax Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-60
-73
-56
-73
24
-149
-209
-318
-285
Operating Cash Flow
-47
-68
-50
-71
29
-133
-160
-274
-322
Investing Cash Flow
-17
51
12
-142
-40
-186
117
-219
290
Financing Cash Flow
75
15
28
304
118
172
264
353
13
Change in Cash
11
-1
-9
90
106
-147
221
-141
-19

Global Institutional Holdings in Syndax Pharmaceuticals Inc

Funds
Holdings
Sphera Funds Management Ltd.
1.82%
Eversept Partners, LP
3.93%
Kynam Capital Management, LP
9.1%
BlackRock Inc
9.78%
BNP Paribas Investment Partners SA
1.68%

Insights on Syndax Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, SNDX has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 25.4% return, outperforming this stock by 22.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, SNDX stock has moved down by -16.2%

About Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor for the treatment of relapsed or refractory R/R acute leukemia; and Niktimvo (axatilimab-csfr), a colony stimulating factor-1 receptor blocking antibody to treat chronic graft-versus-host disease. The company is also developing revumenib for the treatment of R/R acute myeloid leukemia (AML) with a nucleophosmin 1 mutation (mNPM1) and in combination with standard-of-care agents in mNPM1 AML or KMT2Ar acute leukemia, as well as for metastatic colorectal cancer; axatilimab to treat idiopathic pulmonary fibrosis; and Entinostat, a Class 1 HDAC inhibitor. It has an agreement with Eddingpharm International Company Limited for licensing, development, and commercialization of Entinostat. Syndax Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in New York, New York.
OrganisationSyndax Pharmaceuticals Inc
Headquarters730 Third Avenue, New York, NY, United States, 10017
IndustryBiotechnology
CEOMr. Michael A. Metzger M.B.A.
E-voting on sharesClick here to vote

Key Management of Syndax Pharmaceuticals Inc

Name

Title

Dr. Peter Ordentlich B.Sc., Ph.D.

Co-Founder & Chief Scientific Officer

Dr. Richard A. Heyman Ph.D.

Co-Founder

Dr. Michael Downes Ph.D.

Co-Founder

Mr. Kevin McManus

Chief People Officer

Mr. Michael A. Metzger M.B.A.

CEO & Director

Mr. Keith Alan Goldan CPA

CFO, Treasurer & Principal Accounting Officer

Mr. Luke J. Albrecht J.D.

Senior VP, General Counsel & Secretary

Mr. Steven Closter

Chief Commercial Officer

Dr. Ronald M. Evans Ph.D.

Co-Founder, Advisor and Chair of Scientific Advisory Board

Sharon Klahre

Vice President of Investor Relations & Communications

FAQs

What is Syndax Pharmaceuticals Inc share price today?

Syndax Pharmaceuticals Inc share price today is $20.48 as on . Syndax Pharmaceuticals Inc share today touched a day high of $20.84 and a low of $20.48.

What is the 52 week high and 52 week low for Syndax Pharmaceuticals Inc share?

Syndax Pharmaceuticals Inc share touched a 52 week high of $25.59 on and a 52 week low of $8.58 on . Syndax Pharmaceuticals Inc stock price today i.e. is trending at $20.48,which is 19.97% down from its 52 week high and 138.69% up from its 52 week low.

What is Syndax Pharmaceuticals Inc's market capitalisation today?

Syndax Pharmaceuticals Inc market capitalisation is $0.00T as on .

How to invest in Syndax Pharmaceuticals Inc Stock (SNDX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Syndax Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Syndax Pharmaceuticals Inc Shares that will get you 0.0732 shares as per Syndax Pharmaceuticals Inc share price of $20.48 per share as on May 7, 2026 at 7:40 pm IST.

What is the minimum amount required to buy Syndax Pharmaceuticals Inc Stock (SNDX) from India?

Indian investors can start investing in Syndax Pharmaceuticals Inc (SNDX) shares with as little as ₹94.24 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹942.40 in Syndax Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Syndax Pharmaceuticals Inc share’s latest price of $20.48 as on May 7, 2026 at 7:40 pm IST, you will get 0.4883 shares of Syndax Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that Syndax Pharmaceuticals Inc has given to Indian investors in the last 5 years?

Syndax Pharmaceuticals Inc stock has given 28.74% share price returns and 29.81% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?